NCT04706273View on ClinicalTrials.gov

GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03)

CompletedOBSERVATIONAL
Enrollment

321

Participants

Timeline

Start Date

August 25, 2016

Primary Completion Date

July 11, 2019

Study Completion Date

December 14, 2022

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

GORE® VIABAHN® Endoprosthesis

Participants receiving the GORE® VIABAHN® Endoprosthesis

Trial Locations (1)

Unknown

Kansai Rousai, Amagasaki

All Listed Sponsors
lead

W.L.Gore & Associates

INDUSTRY

NCT04706273 - GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03) | Biotech Hunter | Biotech Hunter